Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
van der Poel
Henk G
HG
D000728:Androgens / Q000627:therapeutic use; D002369:Castration; D017321:Clinical Trials, Phase I as Topic; D004967:Estrogens / Q000378:metabolism; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
D000728:Androgens; D004967:Estrogens; D013739:Testosterone